Letter to the Editor

SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People

1. Xia S, Zhang Y, Wang Y, et al (2021). Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis, 21(1):39-51.
2. Kim JH, Marks F, Clemens JD (2021). Looking beyond COVID-19 vaccine phase 3 trials. Nat Med, 27:205–211.
3. BBC News COVID-19 (2021). What do we know about China's coronavirus vac-cines? Available from: https://www.bbc.com/news/world-asia-china-55212787
4. Hayder H (2021). ProPakistan. Here’s a Comparison of All Vaccines Approved in Pakistan. Available from: https://propakistani.pk/2021/04/20/heres-a-comparison-of-all-vaccines-approved-in-pakistan/
5. Strategic advisory group of experts on im-munization (2021). Evidence Assess-ment:Sinopharm/BBIBP COVID-19 vaccine. Available from: https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/2_sage29apr2021_critical-evidence_sinopharm.pdf
6. Saeed U, Uppal SR, Piracha ZZ, et al (2021). Estimating SARS-CoV-2 Spike Antibody Levels Among Sputnik V First Dose Vaccinated People in Pakistan: Formula-tion of Anti-COVID-19 National Mass Vaccination Strategy. Available from : https://assets.researchsquare.com/files/rs-502338/v1/24c611c9-e276-4ebd-a02a-8130df96b036.pdf
7. Saeed U, Uppal SR, Piracha ZZ, et al (2021). Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national test-ing strategy. Virol J, 18(1):34.
8. Saeed U, Uppal SR, Piracha ZZ, et al (2021). Effectivity Analysis of SARS-CoV-2 Na-sopharyngeal Swab Rapid Testing Kits in Pakistan: A Scenario of Inadequate COVID-19 Diagnosis. Available from : https://www.researchsquare.com/article/rs-315851/v1
9. Saeed U, Uppal SR, Piracha ZZ, Uppal R (2021). COVID-19 Transmission via Fomites at Low Temperature: A Potential Silent SARS-CoV-2 Propagation Route. Am J Biomed Sci Res, 12(1) AJBSR.MS.ID.001716.
10. Saeed U, Rizwan Uppal S, Zahid Piracha Z, Uppal R (2021). Azithromycin Treatment for SARS-CoV-2-related COVID-19 Pandemic Could Worsen Extensively Drug Resistant (XDR) Typhoid: A Risk of Losing the Last Bullet against Salmonel-la enterica Serovar Typhi. Jundishapur J Mi-crobiol,14(1):e113874.
Files
IssueVol 50 No 7 (2021) QRcode
SectionLetter to the Editor
Published2021-07-01
DOI https://doi.org/10.18502/ijph.v50i7.6640

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Saeed U, Uppal S, Piracha Z, Uppal R. SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People. Iran J Public Health. 50(7):1486-1487.